HK1197085A1 - Genetic variants for predicting risk of breast cancer - Google Patents
Genetic variants for predicting risk of breast cancerInfo
- Publication number
- HK1197085A1 HK1197085A1 HK14110581A HK14110581A HK1197085A1 HK 1197085 A1 HK1197085 A1 HK 1197085A1 HK 14110581 A HK14110581 A HK 14110581A HK 14110581 A HK14110581 A HK 14110581A HK 1197085 A1 HK1197085 A1 HK 1197085A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- breast cancer
- genetic variants
- predicting risk
- predicting
- risk
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B99/00—Subject matter not provided for in other groups of this subclass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IS50016 | 2011-06-16 | ||
PCT/IS2012/050009 WO2012172575A1 (en) | 2011-06-16 | 2012-06-14 | Genetic variants for predicting risk of breast cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1197085A1 true HK1197085A1 (en) | 2015-01-02 |
Family
ID=47356620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK14110581A HK1197085A1 (en) | 2011-06-16 | 2014-10-23 | Genetic variants for predicting risk of breast cancer |
Country Status (4)
Country | Link |
---|---|
US (1) | US20140329719A1 (xx) |
EP (1) | EP2721180A4 (xx) |
HK (1) | HK1197085A1 (xx) |
WO (1) | WO2012172575A1 (xx) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015035415A1 (en) * | 2013-09-09 | 2015-03-12 | Nantomics, Llc | Method of detecting suceptibility to breast cancer through mutations in the fgfr3 and tp53 genes |
CN104035889B (zh) * | 2014-06-18 | 2017-02-22 | 中国人民解放军信息工程大学 | 一种多态路由派生方法及系统 |
US10867705B2 (en) * | 2014-11-06 | 2020-12-15 | Ancestryhealth.Com, Llc | Predicting health outcomes |
US9859394B2 (en) | 2014-12-18 | 2018-01-02 | Agilome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
US10020300B2 (en) | 2014-12-18 | 2018-07-10 | Agilome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
CA2971589C (en) | 2014-12-18 | 2021-09-28 | Edico Genome Corporation | Chemically-sensitive field effect transistor |
US10006910B2 (en) | 2014-12-18 | 2018-06-26 | Agilome, Inc. | Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same |
US9618474B2 (en) | 2014-12-18 | 2017-04-11 | Edico Genome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
US9857328B2 (en) | 2014-12-18 | 2018-01-02 | Agilome, Inc. | Chemically-sensitive field effect transistors, systems and methods for manufacturing and using the same |
EP3459115A4 (en) | 2016-05-16 | 2020-04-08 | Agilome, Inc. | GRAPHEN-FET DEVICES, SYSTEMS AND METHODS FOR USE THEREOF FOR SEQUENCING NUCLEIC ACIDS |
US11810672B2 (en) * | 2017-10-12 | 2023-11-07 | Nantomics, Llc | Cancer score for assessment and response prediction from biological fluids |
TWI661198B (zh) * | 2018-01-26 | 2019-06-01 | 長庚大學 | 診斷或預斷人類口腔癌的方法 |
CN113707222A (zh) * | 2021-07-28 | 2021-11-26 | 邢传华 | 用于预测预定疾病风险的方法、计算设备和存储介质 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070092900A1 (en) * | 2005-10-26 | 2007-04-26 | Stacey Simon N | Methods for diagnosing and characterizing breast cancer and susceptibility to breast cancer |
WO2008117314A2 (en) * | 2007-03-26 | 2008-10-02 | Decode Genetics Ehf | Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment |
EA018444B1 (ru) * | 2007-05-25 | 2013-08-30 | Декоуд Дженетикс Ехф. | ГЕНЕТИЧЕСКИЕ ВАРИАНТЫ В Chr 5p12 И 10q26 В КАЧЕСТВЕ МАРКЕРОВ ДЛЯ ПРИМЕНЕНИЯ ПРИ ОЦЕНКЕ РИСКА, ДИАГНОСТИРОВАНИИ, ПРОГНОЗИРОВАНИИ И ЛЕЧЕНИИ РАКА ГРУДИ |
EP2215253B1 (en) * | 2007-09-26 | 2016-04-27 | Navigenics, Inc. | Method and computer system for correlating genotype to phenotype using population data |
WO2009097270A2 (en) * | 2008-01-28 | 2009-08-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Method of determining breast cancer risk |
CA2729934A1 (en) * | 2008-07-07 | 2010-01-14 | Decode Genetics Ehf | Genetic variants for breast cancer risk assessment |
-
2012
- 2012-06-14 WO PCT/IS2012/050009 patent/WO2012172575A1/en unknown
- 2012-06-14 US US14/126,828 patent/US20140329719A1/en not_active Abandoned
- 2012-06-14 EP EP12800878.6A patent/EP2721180A4/en not_active Withdrawn
-
2014
- 2014-10-23 HK HK14110581A patent/HK1197085A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP2721180A1 (en) | 2014-04-23 |
WO2012172575A1 (en) | 2012-12-20 |
EP2721180A4 (en) | 2015-09-02 |
US20140329719A1 (en) | 2014-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276488B (en) | A method for predicting breast cancer prognosis | |
HK1197085A1 (en) | Genetic variants for predicting risk of breast cancer | |
EP2686443A4 (en) | GENETIC VARIANTS USEFUL IN ESTIMATING THE RISK OF THYROID CANCER | |
IL228738A0 (en) | Antibodies for cancer treatment | |
HK1201413A1 (en) | Treatment of breast cancer | |
HK1254859A1 (zh) | 治療乳腺癌的方法 | |
HK1197182A1 (en) | Cancer immunotherapy | |
EP2691547A4 (en) | GENE EXPRESSION PREDICTORS FOR CANCER PROSPECTS | |
EP2698634A4 (en) | BIOMARKER FOR BREAST CANCER | |
GB201102014D0 (en) | Method for predicting risk of developing cancer | |
EP2648754A4 (en) | METHODS OF INHIBITING THE METASTASIS OF CANCER | |
EP2707710A4 (en) | DIAGNOSIS OF CANCER | |
IL228430A0 (en) | Cancer treatment | |
GB201120860D0 (en) | Cancer immunotherapy | |
EP2894477A4 (en) | METHOD FOR DETECTION OF BREAST CANCER | |
GB2510539B (en) | Biomarkers of cancer | |
EP2771695A4 (en) | METHOD OF DETECTION OF BREAST CANCERS | |
EP2649225A4 (en) | BIOMARKERS FOR THE PREDICTION OF BREAST CANCER | |
EP2732287A4 (en) | METHOD FOR THE DIAGNOSIS OF CANCER | |
GB201103407D0 (en) | Genetic association | |
EP2769225A4 (en) | BIOLOGICAL MARKERS PREDICTIVE FOR BREAST CANCER | |
IL229109A0 (en) | Cancer diagnosis | |
AP3297A (en) | Direct electrowinning of cobalt | |
GB201121783D0 (en) | Treatment of cancer | |
GB201222952D0 (en) | Treatent of cancer |